NYSE · Healthcare · Healthcare Plans

CVS Health Corporation (CVS)

As of Nov 12, 10:59 AM ET, CVS Health (CVS) last traded at $89.10, down 0.47% on the day. Its TickerHum research score is 57/100 (average). It reported revenue of $420.61B for the twelve months ending 2026-09-30, up 6.7% year over year, with a 3.6% operating margin.

Ratings

Reported fundamentals

MetricValuePeriod
Revenue$420.61BTTM ending 2026-09-30 · 10-Q
Revenue growth6.7%TTM ending 2026-09-30 · 10-Q
Net income$11.04BTTM ending 2026-09-30 · 10-Q
Diluted EPS$8.61TTM ending 2026-09-30 · 10-Q
Operating margin3.6%TTM ending 2026-09-30 · 10-Q
Net margin2.6%TTM ending 2026-09-30 · 10-Q
Free cash flow$15.57BTTM ending 2026-09-30 · 10-Q
Cash$11.74Bas of 2026-09-30 · 10-Q
Long-term debt$57.22Bas of 2026-09-30 · 10-Q
Debt / equity0.71as of 2026-09-30 · 10-Q

Source: SEC EDGAR XBRL company facts (CIK 0000064803).

Comparable companies for CVS Health

Selected by industry, business overlap and scale; these are not necessarily direct competitors.

Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.